Found: 9
Select item for more details and to access through your institution.
Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 9, p. 827, doi. 10.1007/s40261-020-00937-z
- By:
- Publication type:
- Article
ROKSADUSTAT ZA LIJEČENJE ANEMIJE U BOLESNIKA S KRONIČNOM BUBREŽNOM BOLEŠĆU KOJI NISU NA DIJALIZI: RANDOMIZIRANO, OTVORENO, AKTIVNIM LIJEKOM KONTROLIRANO ISPITIVANJE FAZE 3 (DOLOMITES).
- Published in:
- Acta Medica Croatica, 2022, v. 76, n. 1, p. 61
- By:
- Publication type:
- Article
Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 7, p. 2845, doi. 10.1007/s12325-024-02849-2
- By:
- Publication type:
- Article
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).
- Published in:
- Advances in Therapy, 2021, v. 38, n. 10, p. 5361, doi. 10.1007/s12325-021-01904-6
- By:
- Publication type:
- Article
Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES).
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 4, p. 805, doi. 10.1093/ndt/gfab349
- By:
- Publication type:
- Article
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES).
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 9, p. 1616, doi. 10.1093/ndt/gfab191
- By:
- Publication type:
- Article
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS).
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 9, p. 1629, doi. 10.1093/ndt/gfab057
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 435, doi. 10.1002/cpdd.273
- By:
- Publication type:
- Article
Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate‐to‐severe plaque psoriasis.
- Published in:
- Biopharmaceutics & Drug Disposition, 2018, v. 39, n. 5, p. 245, doi. 10.1002/bdd.2130
- By:
- Publication type:
- Article